Cost Analysis of Biliary Drainage Using Metal versus Plastic Stents in Hepatocellular Carcinoma Patients with

Esam Elshimi1, Wesam Morad2

  • 1Hepatology Department, National Liver Institute, Menoufia University, Shebin Al-Kom, Egypt.

Insights

For hepatocellular carcinoma (HCC) patients with biliary obstruction, metal stents are more cost-effective than plastic stents for biliary drainage. This approach reduces overall healthcare expenses and improves patient outcomes.

Area of Science:

  • Gastroenterology
  • Oncology
  • Health Economics

Background:

  • Biliary obstruction in hepatocellular carcinoma (HCC) management remains controversial.
  • Endoscopic stenting offers a minimally invasive option to enhance patient quality of life.

Purpose of the Study:

  • To conduct a cost-effectiveness evaluation of metal versus plastic stents for biliary drainage in HCC patients.
  • To compare clinical efficacy and total costs in a randomized trial.

Main Methods:

  • A randomized trial involving 90 patients with HCC-induced biliary obstruction.
  • 1-year follow-up assessing clinical effectiveness and evaluating total direct and indirect costs.

Main Results:

  • Direct costs per patient: EGP 40,857.84 (plastic) vs. EGP 21,802.62 (metal).
  • Indirect costs per patient: EGP 888 (plastic) vs. EGP 454 (metal).
  • Plastic stents incurred higher costs due to repeat procedures, medication, consultations, and hospitalizations.

Conclusions:

  • Metal stents are a more cost-effective solution for biliary drainage in HCC patients.
  • The findings support the preferential use of metal stents to optimize resource allocation.
Abstract

Related Concept Videos